ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,005,015 | +3110.2% | 275,788 | +5026.2% | 0.02% | +1700.0% |
| Q4 2022 | $218,213 | -97.1% | 5,380 | -97.6% | 0.00% | -95.7% |
| Q3 2022 | $7,459,000 | +20.2% | 225,683 | +28.1% | 0.02% | +15.0% |
| Q2 2022 | $6,204,000 | +568.5% | 176,194 | +773.1% | 0.02% | +566.7% |
| Q1 2022 | $928,000 | +36.5% | 20,181 | +96.8% | 0.00% | +50.0% |
| Q4 2021 | $680,000 | -91.4% | 10,257 | -91.9% | 0.00% | -93.9% |
| Q3 2021 | $7,895,000 | -26.7% | 126,470 | -2.7% | 0.03% | -35.3% |
| Q2 2021 | $10,767,000 | +306.3% | 130,000 | +276.3% | 0.05% | +240.0% |
| Q4 2020 | $2,650,000 | +105.1% | 34,543 | +15.1% | 0.02% | +66.7% |
| Q3 2020 | $1,292,000 | +92.5% | 30,000 | +183.7% | 0.01% | +125.0% |
| Q4 2019 | $671,000 | – | 10,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |